📰 Bedema News
Page 12 - Bedema News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bedema. Real-time updates on events, politics, business and more.
June 2, 2022
Abdominal CT detects internal herniation in patients after Roux-en-Y gastric bypass surgery and helps doctors determine who may benefit from exploratory surgery, researchers report.
May 9, 2022
A new study published in the Journal of Pediatric Infectious Diseases Society aimed to characterize the clinical features of SARS-CoV-2-associated croup among children presenting to the ED during the phase when Omicron variant transmission was high.
May 3, 2022
Leuven, BELGIUM, Boston, MA, US - May 3, 2022 - 7:10 PM CET - Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies
May 2, 2022
Case raises concerns about long-term consequences of undetected myocardial involvement
April 29, 2022
Substantial Toxic Effects of Breast Radiotherapy Often Missed
April 28, 2022
A team of Italian scientists has presented case reports of five coronavirus disease 2019 (COVID-19) patients undergoing emergency surgery for intestinal ischemia.
April 27, 2022
Get your own copy of this album at SwapaCD.com. If you're not yet a member, your first 2 cds and membership are free! All you have to do is post 10 cds you want to get rid of. Visit the site to find a huge selection of music!
April 21, 2022
Stay asleep wake refreshed with clinically proven relaxium sleep act now youll be glad you did trust me like your jim clyburn of south carolina is one of those powerful democratss in the house did more than any other democrat to get joe bideni presidential nomination is alsou corrupt. and if you think thats a a reckless charge to make,ne listen to the evidence boxes. kevin corke hasas a story of an evening. >> tucker , it is important to m note that yes,portan bill , dema and republicans at vari...
April 21, 2022
New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years.
April 11, 2022
Leuven, BELGIUM, Boston, MA, US - 11 April 2022 - 7.00 AM CET - Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a